Name | Cyclo(L-alanyl-L-α-aspartyl-D-phenylalanyl-L-lysyl-L-arginyl) |
---|---|
Synonyms |
Cyclo(L-alanyl-L-α-aspartyl-D-phenylalanyl-L-lysyl-L-arginyl)
cyclo (Arg-Ala-Asp-d-Phe-Lys) Cyclo(RADfK) |
Description | Cyclo(RADfK) is a selective α(v)β(3) integrin ligand that has been extensively used for research, therapy, and diagnosis of neoangiogenesis. Sequence: Cyclo(Ala-Asp-Phe-Lys-Arg). |
---|---|
Related Catalog | |
Target |
Integrin[1]. |
In Vitro | Cyclo(RADfK) is a negative control for the cyclo (-RGDfK-), the RGD peptide. RGD peptides are modulators of cell adhesion and are recognized by several members of the integrin family[1]. |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Molecular Formula | C28H43N9O7 |
Molecular Weight | 617.69700 |
Exact Mass | 617.32900 |
PSA | 270.72000 |
LogP | -2.75 |
Index of Refraction | 1.659 |
Storage condition | -20°C |